Beijing Strong Biotechnologies Inc (300406) - Total Liabilities
Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has total liabilities worth CN¥1.30 Billion CNY (≈ $190.20 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Beijing Strong Biotechnologies Inc (300406) equity growth momentum to track the company's year-over-year net asset growth rate.
Beijing Strong Biotechnologies Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how Beijing Strong Biotechnologies Inc's total liabilities have evolved over time, based on quarterly financial data. See how much free cash does Beijing Strong Biotechnologies Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Beijing Strong Biotechnologies Inc Competitors by Total Liabilities
The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
UP FINT. HLDG (SP.ADR) A
F:1M5
|
Germany | €8.48 Billion |
|
EPIC Suisse AG
SW:EPIC
|
Switzerland | CHF870.23 Million |
|
Amoy Diagnostics Co Ltd
SHE:300685
|
China | CN¥272.62 Million |
|
Miracle Automation Engineering
SHE:002009
|
China | CN¥3.47 Billion |
|
CHINA RISUN GROUP HD-10
F:45Y
|
Germany | €46.78 Billion |
|
Leedarson IoT Technology Inc
SHG:605365
|
China | CN¥2.80 Billion |
|
Nutex Health Inc
NASDAQ:NUTX
|
USA | $515.26 Million |
|
Jiangsu Ankura Smart Transmission Engineering Technology Co Ltd
SHE:300617
|
China | CN¥861.58 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Beijing Strong Biotechnologies Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Beijing Strong Biotechnologies Inc.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 11.66 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.32 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.25 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Strong Biotechnologies Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Strong Biotechnologies Inc (2011–2024)
The table below shows the annual total liabilities of Beijing Strong Biotechnologies Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥1.44 Billion ≈ $211.03 Million |
-0.83% |
| 2023-12-31 | CN¥1.45 Billion ≈ $212.79 Million |
+8.19% |
| 2022-12-31 | CN¥1.34 Billion ≈ $196.69 Million |
-4.43% |
| 2021-12-31 | CN¥1.41 Billion ≈ $205.79 Million |
+160.34% |
| 2020-12-31 | CN¥540.20 Million ≈ $79.05 Million |
+195.05% |
| 2019-12-31 | CN¥183.09 Million ≈ $26.79 Million |
+12.65% |
| 2018-12-31 | CN¥162.52 Million ≈ $23.78 Million |
-34.64% |
| 2017-12-31 | CN¥248.65 Million ≈ $36.39 Million |
+199.26% |
| 2016-12-31 | CN¥83.09 Million ≈ $12.16 Million |
-4.01% |
| 2015-12-31 | CN¥86.56 Million ≈ $12.67 Million |
+50.68% |
| 2014-12-31 | CN¥57.44 Million ≈ $8.41 Million |
+28.88% |
| 2013-12-31 | CN¥44.57 Million ≈ $6.52 Million |
-4.78% |
| 2012-12-31 | CN¥46.81 Million ≈ $6.85 Million |
+66.97% |
| 2011-12-31 | CN¥28.04 Million ≈ $4.10 Million |
-- |
About Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more